Biotech Specialty Pharma

Revance Therapeutics

7555 Gateway Boulevard
Newark,, CA 94560 USA
Click for website

Research Sector Biotech Specialty Pharma

Summary Description Products for treating skin and improving aesthetic appearance.

Management Dan Browne, Co-Founder, President & Chief Executive Officer; Jacob Waugh, MD, Co-Founder & Chief Scientific Officer; R. Todd Plott, MD, Chief Medical Officer; David Styka, Chief Financial Officer; Curtis Ruegg, Ph.D., Executive Vice President, Research and Development; Sharon Hall, Vice President of Regulatory Affairs; Niquette Hunt, Vice President of Marketing and Business Development; Debbie Tranowski, Vice President of Clinical Operations and Project Management

Click here for Financial Data
Keywords: Aesthetics, plastic surgery, skin care


Updated: May 29, 2013


Revance Therapeutics is focused on the discovery, development and commercialization of novel products to treat skin and improve aesthetic appearance.......view more

Products / Services

Revance's initial focus is to develop and commercialize botulinum toxin type A (BoNT-A) products for indications where the benefit of topical application provides a meaningful advantage over the injec......view more

Technology / Differentiation

The Revance TransMTS technology enables transcutaneous delivery of large macromolecules, eliminating the need for injections or other invasive procedures....view more